Imperial plans to open its newest Imperial Global hub in India in May 2025. Imperial – ranked second best university in the ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.    Patients who receive an ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

Imperial College London research reveals the cholesterol-lowering drug ezetimibe could slash risk of heart attack patients ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Academic medicine is in urgent need of a revolution, say experts in the first report of The BMJ Commission on the Future of ...

MEN struck down by a ‘spring cold’ could be at risk of fertility issues, a new study suggests. Scientists in China found men ...

This month the Dictionary of Irish Biography is publishing 22 new and updated biographical entries of important Irish figures ...

Diagnosis of neurodegenerative disease is currently often made too late in the disease progression for effective treatment to ...

To address the growing health threats posed by climate change, Nanyang Technological University, Singapore (NTU Singapore) is ...

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

Glasgow will host the UK’s pandemic preparedness conference on 23 April 2025, bringing together key experts from UK public ...